58826-40-7

Usage

Structure

Heterocyclic compound containing a pyridazine ring fused with a triazolo ring

Application

Used in the pharmaceutical industry for potential drug development

Potential

Shows promise in various biological and medicinal studies

Current Status

Under investigation for potential medical uses

Specific Content

6-Chloro-8-Methyl-[1,2,4]Triazolo[4,3-B]Pyridazine

Upstream product

• 64-18-6 formic acid 
• 66530-55-0 6-chloro-3-hydrazino-4-methylpyridazine 
• 19064-64-3 3,6-dichloro-4-methylpyridazine 

Downstream Products

• 56383-06-3 8-methyl-6-morpholino[1,2,4]triazolo[4,3-b]pyridazine 

Relevant academic research and scientific papers

Nucleophilic substitution and lipophilicity - Structure relations in methylazolopyridazines

Syntheses of methyl[1,2,4]triazolo- or methyltetrazolopyridazine isomers, their separation and nucleophilic substitution with morpholine, dimethylamine and hydrazine have been described. The lipophilicity of the azolopyridazines has been measured and rela

6-Hydroxyalkylamino-8-methyl-1,2,4-triazolo-[4,3-b]pyridazine and related compounds

8-Methyl-1,2,4-triazolo[4,3-b]pyridazines having a hydroxyalkylamino substituent at the 6-position are described herein. The compounds involved are useful as bronchodilator agents and they are prepared by the reaction of 6-chloro-8-methyl-1,2,4-triazolo[4,3-b]-pyridazine with an appropriate amino alcohol.